MedTrace Logo

Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department

NCT01947127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 458

Last updated 2016-12-02

Study results available
· View outcomes & findings →

Summary

To investigate the role of initial venous lactate in predicting the severity progression to overt septic shock and 30-day mortality in non-elderly patients without hemodynamic shock who suspected to have acute infections.

Conditions

  • Sepsis
  • Disease Progression
  • Septic Shock
  • Fatal Outcome

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Khrongwong Musikatavorn, MD · Department of Medicine, Facalty of medicine, Chulalongkorn University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-11-30
Completion
2015-01-31

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947127 on ClinicalTrials.gov